The Pharmaletter

One To Watch

sqz_biotech_company

SQZ Biotech

The novel SQZ Cell Therapy Platform uses membrane disruption to deliver material into cells.

SQZ has demonstrated delivery of a wide range of materials into numerous primary cell types with minimal impact on function and viability. "This differentiating capability enables one to engineer diverse cellular functions and create a broad range of cell therapies for multiple therapeutic areas."

Want to Update your Company's Profile?


More SQZ Biotech news >